Board

C4X Discovery is guided by a Board with extensive expertise in drug discovery and development, clinical trials, transactions and fundraising. The team is detailed below.

Brad Hoy

Brad has more than 20 years’ experience in the pharmaceutical and biotechnology industries and has held a number of senior financial and general management positions in both the UK and the US. Previously, Brad was chief financial officer of Plethora Solutions Holdings plc, an AIM-listed specialty pharmaceutical company, chief executive officer of Xcellsyz Limited, a UK venture capital-backed life science company, and senior director of Geron Corporation’s stem cell-focussed UK subsidiary. Brad is a co-founder of Seven Hills Venture Partners, a life sciences advisory firm, and previously served as non-executive director on the board of directors for e-Therapeutics plc for nine years.

For information on the role of the Board click HERE.